Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
出版年份 2017 全文链接
标题
Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 23, Issue 31, Pages 5764
出版商
Baishideng Publishing Group Inc.
发表日期
2017-08-19
DOI
10.3748/wjg.v23.i31.5764
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dclk1 Defines Quiescent Pancreatic Progenitors that Promote Injury-Induced Regeneration and Tumorigenesis
- (2016) C. Benedikt Westphalen et al. Cell Stem Cell
- DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer
- (2016) Tianbo Gao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation
- (2015) Yu-Hong Liu et al. Oncotarget
- DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
- (2015) Nathaniel Weygant et al. Oncotarget
- DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition
- (2015) Parthasarathy Chandrakesan et al. Oncotarget
- XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism
- (2014) Sripathi M. Sureban et al. CANCER LETTERS
- Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer
- (2014) Peter Bronsert et al. SURGERY
- Histological and prognostic importance of CD44+/CD24+/EpCAM+expression in clinical pancreatic cancer
- (2013) Yusuke Ohara et al. CANCER SCIENCE
- DCLK1 Marks a Morphologically Distinct Subpopulation of Cells With Stem Cell Properties in Preinvasive Pancreatic Cancer
- (2013) Jennifer M. Bailey et al. GASTROENTEROLOGY
- DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer
- (2013) Sripathi M. Sureban et al. PLoS One
- Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer
- (2013) Suguru Yamada et al. SURGERY
- Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone
- (2013) Akihiro Murata et al. World Journal of Surgical Oncology
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dclk1 distinguishes between tumor and normal stem cells in the intestine
- (2012) Yuki Nakanishi et al. NATURE GENETICS
- DCAMKL-1 Regulates Epithelial-Mesenchymal Transition in Human Pancreatic Cells through a miR-200a-Dependent Mechanism
- (2011) S. M. Sureban et al. CANCER RESEARCH
- Identification of the putative intestinal stem cell marker doublecortin and CaM kinase-like-1 in Barrett's esophagus and esophageal adenocarcinoma
- (2011) Kenneth J Vega et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer
- (2011) Hiroshi Kurahara et al. JOURNAL OF SURGICAL ONCOLOGY
- Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity
- (2011) H Akita et al. ONCOGENE
- Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanism
- (2011) Sripathi M Sureban et al. JOURNAL OF NANOBIOTECHNOLOGY
- Doublecortin and CaM Kinase-like-1 and Leucine-Rich-Repeat-Containing G-Protein-Coupled Receptor Mark Quiescent and Cycling Intestinal Stem Cells, Respectively
- (2009) Randal May et al. STEM CELLS
- Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal Adenocarcinoma
- (2008) Justin M.M. Cates et al. PANCREAS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started